CHRYSTAL DAUGHERTY: Open Payments
NPI 1588434450 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 17 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $143 |
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| Amgen Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: QULIPTA, FANAPT, VRAYLAR, UBRELVY, OTEZLA, CAPLYTA, ARISTADA, BREZTRI.
Industry payments across KY — which companies pay providers there.
